Skip to main content

Table 3 Significant patient-reported outcome predictors of adherence to supervised exercise in the CARE Trial, 2008–2011, Canada

From: Predictors of adherence to different types and doses of supervised exercise during breast cancer chemotherapy

  

Correlation1

ANOVA2

Variable

M ± SD (%)

r; p value

F; p value

Physical well-being

 

.12; 0.036

2.5; 0.081

 < 23 (n = 98)

69% ± 24%

  

 23-25.9 (n = 93)

74% ± 25%

  

 ≥ 26 (n = 110)

76% ± 24%

  

Taxane/neuropathy symptoms

 

.17; .003

3.2; 0.043

 < 61 (n = 83)

68% ± 25%

  

 61-63 (n = 102)

73% ± 24%

  

 64 (n = 116)

77% ± 23%

  

Endocrine symptoms

 

.17; 0.003

1.5; 0.21

 ≤ 65 (n = 104)

70% ± 24%

  

 66-71 (n = 99)

74% ± 23%

  

 > 71 (n = 98)

75% ± 25%

  
  1. Note. 1Tested the association as a continuous variable. 2Tested the association as a predefined categorical variable.